LivingGLP1
Study S002778

A Phase I, Open-label, Fixed-sequence Study to Evaluate the Effect of Repeated Subcutaneous Injections of GZR18 Injection on the Pharmacokinetics of Oral Metformin Hydrochloride Tablets in Overweight/Obese Subjects

ClinicalTrials.gov record

Registration

Registration
NCT06670209
Study type
INTERVENTIONAL
Phase
PHASE1
Masking
NONE
Status
NOT_YET_RECRUITING
Enrollment
32
Start
2024-10-30
Primary completion
2025-03-19
Lead sponsor
Gan and Lee Pharmaceuticals, USA
Conditions
Type 2 Diabetes
Interventions
DRUG:GZR18 and metformin
Results posted
FALSE

Registered primary outcomes

  • Cmax,ss [24 hours]
  • AUC0-tau [24 hours]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.